A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie raka piersi (etap 1-3) bez receptorów hormonalnych
- •Wiek 18 lat lub więcej
- •Od 1 do 12 miesięcy po zakończeniu leczenia
- •Odczuwanie stresu minimum 4/10 w skali oceny
- •Umiejętność czytania i odpowiadania po angielsku lub hiszpańsku
✗ Disqualifies
- •Rak w zaawansowanym stadium (etap 4)
- •Problemy z pamięcią lub myśleniem uniemożliwiające udział w badaniu
- •Poważne problemy psychiczne uniemożliwiające udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- June 15, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Massachusetts General Hospital
Boston, United States
Trial contact
Kathryn E Post, PhD, RN, ANP-BC
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.